Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Several vaccine candidates to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19) have entered or will soon enter large-scale, phase 3, placebo-controlled randomized clinical trials. To facilitate harmonized evaluation and com...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Intern Med
Hlavní autoři: Mehrotra, Devan V., Janes, Holly E., Fleming, Thomas R., Annunziato, Paula W., Neuzil, Kathleen M., Carpp, Lindsay N., Benkeser, David, Brown, Elizabeth R., Carone, Marco, Cho, Iksung, Donnell, Deborah, Fay, Michael P., Fong, Youyi, Han, Shu, Hirsch, Ian, Huang, Ying, Huang, Yunda, Hyrien, Ollivier, Juraska, Michal, Luedtke, Alex, Nason, Martha, Vandebosch, An, Zhou, Honghong, Cohen, Myron S., Corey, Lawrence, Hartzel, Jonathan, Follmann, Dean, Gilbert, Peter B.
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Physicians 2020
Témata:
Research and Reporting Methods
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596738/
https://ncbi.nlm.nih.gov/pubmed/33090877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-6169
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky